Key points from article :
Immortal Dragons is a longevity-focused investment fund based in Singapore with $40 million under management. Founded by tech entrepreneur Boyang Wang, the fund supports companies working to delay aging and extend healthy life. It sees aging and death not as inevitable, but as scientific problems that can be solved. The team has already invested in over 15 startups across areas like gene therapy, 3D bioprinting, cryopreservation, and regenerative medicine. These technologies aim to repair or replace aging organs, tackle root causes of aging, and create new tools to speed up clinical trials.
What makes Immortal Dragons unique is that it operates with its own money under a single investor. This allows quick decisions and a focus on high-impact, long-term projects that traditional investors often avoid. The fund also works to grow the longevity movement through education. It translates books, supports scientific conferences, and funds Chinese-language platforms to bring global research to a wider audience.
Their goal is to connect funding, science, and public support to reshape how we think about aging. The fund builds strong ties between Eastern and Western markets and aims to make life-extension technologies accessible to everyone. Their message: aging is a problem we can—and should—solve.
